Semaglutide 10mg
GLP-1 Weight Management
View Certificate of AnalysisCompound Overview
Semaglutide is a GLP-1 receptor agonist peptide originally developed by Novo Nordisk. It is one of the most extensively studied metabolic peptides in clinical research, with approved pharmaceutical formulations (Ozempic®, Wegovy®) demonstrating its significance in the incretin pathway. This 10mg research-grade vial provides lyophilized semaglutide at ≥99% purity, independently verified by Testides (Toronto).
Lab results: View current batch COA
Compare in our Semaglutide vs Tirzepatide vs Retatrutide Comparison Guide.
Specifications
| Compound | Semaglutide |
| Compound class | GLP-1 receptor agonist peptide (single agonist) |
| Vial contents | 10 mg lyophilized powder |
| Verified purity | ≥99% (HPLC) |
| Testing laboratory | Testides, Toronto (ISO 17025-aligned) |
| Test methods | HPLC purity + mass spectrometry identity confirmation |
| Compatible solvent | Bacteriostatic water (0.9% benzyl alcohol) |
| Storage | Lyophilized: -20°C long-term, 2-8°C short-term. Protect from light |
| Research applications | GLP-1 receptor signalling, incretin pathway, glycaemic regulation, appetite and satiety research, body weight and metabolic studies |
| Related compounds | Tirzepatide (dual agonist), Retatrutide (triple agonist) |
| Ships from | British Columbia, Canada |
| Intended use | In-vitro laboratory research only |
Research Context & Mechanism+
Semaglutide selectively binds to the GLP-1 receptor, mimicking endogenous glucagon-like peptide-1. Key published research includes the STEP 1 trial (Wilding et al., NEJM 2021, PMID: 33567185) demonstrating significant body weight reduction, and the SELECT cardiovascular outcomes trial (Lincoff et al., NEJM 2023, PMID: 37952131) establishing cardiovascular benefit independent of diabetes status.
Researchers commonly study semaglutide alongside tirzepatide (dual agonist) and retatrutide (triple agonist). Read the full comparison →
Purity & Third-Party Testing+
Every batch independently tested by Testides (Toronto) — HPLC ≥99% purity and mass spectrometry identity confirmation. View current batch COA →
Storage & Handling+
Lyophilized: -20°C long-term, 2-8°C short-term. Protect from light.
Shipping & Delivery+
Ships from British Columbia. Tracked Canada-wide. 48-hour processing (Mon-Fri). Temperature-stable, tamper-evident, discreet packaging. Shipping policy →
Returns & Refunds+
Damaged orders: info@thepeptide.ca within 48 hours with order number and photos. Sealed, unopened vials eligible for exchange within 14 days. Full refund policy →
For laboratory and research use only. Not for human consumption, veterinary use, or therapeutic application. Not approved by Health Canada.
- Sealed vial: −20°C, 24+ months.
- Protect from light and heat.
- Keep in original packaging until use in the laboratory.
- CAS: 910463-68-2
- Molecular weight: 4,113.58 g/mol
- Class: GLP-1 receptor agonist
- Purity: ≥99% (HPLC)
Not for human or animal use. We do not publish preparation, dilution or administration guidance of any kind.
By purchasing, you confirm research intent and accept full responsibility for compliance.
Mix any research peptides 10 mg or larger — the discount counts your whole order, not one product.
YOU MAY ALSO LIKE
SHOP ALL
Frequently Bought Together
Laboratory supplies commonly ordered alongside research compounds.
Bacteriostatic Water 10mL — Sterile Multi-Use Laboratory Water with 0.9% Benzyl Alcohol
Essential Reconstitution Supply
STARTING AT ▸ $22.00
Insulin Syringes 10-Pack — 1mL, 29G × ½" Sterile Single-Use Laboratory Syringes
Sterile. Ultra-fine. Individually wra...
Why ThePeptide
Most research peptide sellers ask you to take their word for it. We publish the receipts.
